<!DOCTYPE html><html lang="en-gb" >


<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  
  
  
    <meta name="generator" content="Wowchemy 5.4.0 for Hugo" />
  

  
  









  




  
  
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
  

  
  
  
    
      
      <link rel="preload" as="style" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap">
      <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap" media="print" onload="this.media='all'">
    
  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Gabriel Mateus Bernardo Harrington" />

  
  
  
    
  
  <meta name="description" content="Purpose - Development of novel allogeneic chondrocyte therapies are needed to provide a more widespread, cost-effective cartilage treatment option. Here we investigate the potential of juvenile cartilage sources for allogeneic chondrocyte manufacture. &lt;br&gt;&lt;br&gt; Methods and Materials - Juvenile polydactyly digit (PD; n=4; aged 1±1 years (med±IQR)) or iliac apophysis cartilage (IA; n=6; aged 1±0.5years (med±IQR)) was used to derive chondrocyte cultures. Juvenile chondrocyte growth was compared to adult chondrocytes used for Autologous Chondrocyte Implantation (n=11; aged 41±9 years (med±IQR)). Further, juvenile chondrocytes (PD, n=2; IA, n=3) were up-scale manufactured using the Quantum® hollow-fibre bioreactor and compared to traditional tissue culture plastic (TCP) methods. All data are mean±SD. &lt;br&gt;&lt;br&gt; Results - Comparable chondrocyte yields were obtained from juvenile (IA: 4.3±3.8x103 cells/mg tissue; polydactyly: 4.2±4.2x103 cells/mg tissue) and adult (2.6±0.1x103 cells/mg tissue; p&gt;0.05; One-Way Anova) sources. In contrast, doubling time (DT) (passage 1-3) for PD chondrocytes grown on TCP (2.66±1.57days) was significantly lower than IA (5.17±2.66 days) and adult chondrocytes (9.98±10.29 days) (Paired t-tests; p&lt;0.05). Up-scale bioreactor expansion yielded 74.5±30 x106 PD and 76±14x106 IA chondrocytes in 11±1 days. DT was longer in the bioreactor cf. TCP (IA: bioreactor DT= 3.9±0.2 days, TCP DT= 2.0±0.3 days, t-test, p&lt;0.05; PD: bioreactor DT=3.8±1.0 days, TCP DT=1.3±0.0 days). Juvenile chondrocytes were immunopositive (&gt;95%) for CD90, CD73, CD44, CD166 and CD151 and immunonegative (&lt;2%) for CD19, CD34, and CD45 and no difference in immunoprofile was observed cf. TCP expansion (One-Way ANOVA). &lt;br&gt;&lt;br&gt; Conclusion - Juvenile chondrocytes represent attractive allogeneic cells sources, yielding large numbers of chondrocytes. However, our preliminary analyses indicate that their growth may be slowed upon hollow-fibre bioreactor expansion. Further analysis of key chondrogenic genes and in vitro cartilage forming capacity needs to be conducted in more donors to determine whether chondrogenic potential is influenced by up-scale manufacture." />

  
  <link rel="alternate" hreflang="en-gb" href="https://oskor.netlify.app/publication/juvenile-chondrocytes-novel-alternatives-for-allogeneic-cell-therapy/" />

  
  
  
    <meta name="theme-color" content="#1565c0" />
  

  
  
    
    <script src="/js/mathjax-config.js"></script>
  

  

  <link rel="stylesheet" href="/css/vendor-bundle.min.f1ecf783c14edc00c9320c205831ad8e.css" media="print" onload="this.media='all'">

  
  
  
    
    
      <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/academicons@1.9.1/css/academicons.min.css" integrity="sha512-W0xM4mr6dEP9nREo7Z9z+9X70wytKvMGeDsj7ps2+xg5QPrEBXC8tAW1IFnzjR6eoJ90JmCnFzerQJTLzIEHjA==" crossorigin="anonymous" media="print" onload="this.media='all'">
    

    
    
    
    
      
      
    
    
    

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/styles/github.min.css" crossorigin="anonymous" title="hl-light" media="print" onload="this.media='all'">
          <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" media="print" onload="this.media='all'" disabled>
        
      
    

    
    
    

    

    
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml.js" integrity="" crossorigin="anonymous" async></script>
      
    
      
      

      
      

      
    
      
      

      
      

      
    
  

  
  
  
  
  
  <link rel="stylesheet" href="/css/wowchemy.246129d782c938a644fe2d653d8a976f.css" />

  




<script async src="https://www.googletagmanager.com/gtag/js?id=UA-171428188-2"></script>
<script>
  window.dataLayer = window.dataLayer || [];

  function gtag() {
      dataLayer.push(arguments);
  }

  function trackOutboundLink(url, target) {
    gtag('event', 'click', {
         'event_category': 'outbound',
         'event_label': url,
         'transport_type': 'beacon',
         'event_callback': function () {
           if (target !== '_blank') {
             document.location = url;
           }
         }
    });
    console.debug("Outbound link clicked: " + url);
  }

  function onClickCallback(event) {
    if ((event.target.tagName !== 'A') || (event.target.host === window.location.host)) {
      return;
    }
    trackOutboundLink(event.target, event.target.getAttribute('target'));  
  }

  gtag('js', new Date());
  gtag('config', 'UA-171428188-2', {});
  gtag('set', {'cookie_flags': 'SameSite=None;Secure'});

  
  document.addEventListener('click', onClickCallback, false);
</script>


  

  

  




  
  
  

  

  
    <link rel="manifest" href="/manifest.webmanifest" />
  

  <link rel="icon" type="image/png" href="/media/icon_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_32x32_fill_lanczos_center_3.png" />
  <link rel="apple-touch-icon" type="image/png" href="/media/icon_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_180x180_fill_lanczos_center_3.png" />

  <link rel="canonical" href="https://oskor.netlify.app/publication/juvenile-chondrocytes-novel-alternatives-for-allogeneic-cell-therapy/" />

  
  
  
  
  
  
  
  
    
    
  
  

  
  
    
    
  
  <meta property="twitter:card" content="summary" />
  
    <meta property="twitter:site" content="@CellTherapyRJAH" />
    <meta property="twitter:creator" content="@CellTherapyRJAH" />
  
  <meta property="og:site_name" content="Oswestry Keele Orthopaedic Research group - OsKOR" />
  <meta property="og:url" content="https://oskor.netlify.app/publication/juvenile-chondrocytes-novel-alternatives-for-allogeneic-cell-therapy/" />
  <meta property="og:title" content="Juvenile Chondrocytes: Novel Alternatives for Allogeneic Cell Therapy? | Oswestry Keele Orthopaedic Research group - OsKOR" />
  <meta property="og:description" content="Purpose - Development of novel allogeneic chondrocyte therapies are needed to provide a more widespread, cost-effective cartilage treatment option. Here we investigate the potential of juvenile cartilage sources for allogeneic chondrocyte manufacture. &lt;br&gt;&lt;br&gt; Methods and Materials - Juvenile polydactyly digit (PD; n=4; aged 1±1 years (med±IQR)) or iliac apophysis cartilage (IA; n=6; aged 1±0.5years (med±IQR)) was used to derive chondrocyte cultures. Juvenile chondrocyte growth was compared to adult chondrocytes used for Autologous Chondrocyte Implantation (n=11; aged 41±9 years (med±IQR)). Further, juvenile chondrocytes (PD, n=2; IA, n=3) were up-scale manufactured using the Quantum® hollow-fibre bioreactor and compared to traditional tissue culture plastic (TCP) methods. All data are mean±SD. &lt;br&gt;&lt;br&gt; Results - Comparable chondrocyte yields were obtained from juvenile (IA: 4.3±3.8x103 cells/mg tissue; polydactyly: 4.2±4.2x103 cells/mg tissue) and adult (2.6±0.1x103 cells/mg tissue; p&gt;0.05; One-Way Anova) sources. In contrast, doubling time (DT) (passage 1-3) for PD chondrocytes grown on TCP (2.66±1.57days) was significantly lower than IA (5.17±2.66 days) and adult chondrocytes (9.98±10.29 days) (Paired t-tests; p&lt;0.05). Up-scale bioreactor expansion yielded 74.5±30 x106 PD and 76±14x106 IA chondrocytes in 11±1 days. DT was longer in the bioreactor cf. TCP (IA: bioreactor DT= 3.9±0.2 days, TCP DT= 2.0±0.3 days, t-test, p&lt;0.05; PD: bioreactor DT=3.8±1.0 days, TCP DT=1.3±0.0 days). Juvenile chondrocytes were immunopositive (&gt;95%) for CD90, CD73, CD44, CD166 and CD151 and immunonegative (&lt;2%) for CD19, CD34, and CD45 and no difference in immunoprofile was observed cf. TCP expansion (One-Way ANOVA). &lt;br&gt;&lt;br&gt; Conclusion - Juvenile chondrocytes represent attractive allogeneic cells sources, yielding large numbers of chondrocytes. However, our preliminary analyses indicate that their growth may be slowed upon hollow-fibre bioreactor expansion. Further analysis of key chondrogenic genes and in vitro cartilage forming capacity needs to be conducted in more donors to determine whether chondrogenic potential is influenced by up-scale manufacture." /><meta property="og:image" content="https://oskor.netlify.app/media/logo_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_300x300_fit_lanczos_3.png" />
    <meta property="twitter:image" content="https://oskor.netlify.app/media/logo_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_300x300_fit_lanczos_3.png" /><meta property="og:locale" content="en-gb" />
  
    
      <meta
        property="article:published_time"
        content="2009-07-04T15:53:28&#43;00:00"
      />
    
    <meta property="article:modified_time" content="2022-05-05T12:44:52&#43;01:00">
  

  


    









<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://oskor.netlify.app/publication/juvenile-chondrocytes-novel-alternatives-for-allogeneic-cell-therapy/"
  },
  "headline": "Juvenile Chondrocytes: Novel Alternatives for Allogeneic Cell Therapy?",
  
  "datePublished": "2009-07-04T15:53:28Z",
  "dateModified": "2022-05-05T12:44:52+01:00",
  
  "author": {
    "@type": "Person",
    "name": "Charlotte Hulme"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "Group name (placeholder)",
    "logo": {
      "@type": "ImageObject",
      "url": "https://oskor.netlify.app/media/logo_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_192x192_fit_lanczos_3.png"
    }
  },
  "description": "Purpose - Development of novel allogeneic chondrocyte therapies are needed to provide a more widespread, cost-effective cartilage treatment option. Here we investigate the potential of juvenile cartilage sources for allogeneic chondrocyte manufacture. \u003cbr\u003e\u003cbr\u003e Methods and Materials - Juvenile polydactyly digit (PD; n=4; aged 1±1 years (med±IQR)) or iliac apophysis cartilage (IA; n=6; aged 1±0.5years (med±IQR)) was used to derive chondrocyte cultures. Juvenile chondrocyte growth was compared to adult chondrocytes used for Autologous Chondrocyte Implantation (n=11; aged 41±9 years (med±IQR)). Further, juvenile chondrocytes (PD, n=2; IA, n=3) were up-scale manufactured using the Quantum® hollow-fibre bioreactor and compared to traditional tissue culture plastic (TCP) methods. All data are mean±SD. \u003cbr\u003e\u003cbr\u003e Results - Comparable chondrocyte yields were obtained from juvenile (IA: 4.3±3.8x103 cells/mg tissue; polydactyly: 4.2±4.2x103 cells/mg tissue) and adult (2.6±0.1x103 cells/mg tissue; p\u003e0.05; One-Way Anova) sources. In contrast, doubling time (DT) (passage 1-3) for PD chondrocytes grown on TCP (2.66±1.57days) was significantly lower than IA (5.17±2.66 days) and adult chondrocytes (9.98±10.29 days) (Paired t-tests; p\u003c0.05). Up-scale bioreactor expansion yielded 74.5±30 x106 PD and 76±14x106 IA chondrocytes in 11±1 days. DT was longer in the bioreactor cf. TCP (IA: bioreactor DT= 3.9±0.2 days, TCP DT= 2.0±0.3 days, t-test, p\u003c0.05; PD: bioreactor DT=3.8±1.0 days, TCP DT=1.3±0.0 days). Juvenile chondrocytes were immunopositive (\u003e95%) for CD90, CD73, CD44, CD166 and CD151 and immunonegative (\u003c2%) for CD19, CD34, and CD45 and no difference in immunoprofile was observed cf. TCP expansion (One-Way ANOVA). \u003cbr\u003e\u003cbr\u003e Conclusion - Juvenile chondrocytes represent attractive allogeneic cells sources, yielding large numbers of chondrocytes. However, our preliminary analyses indicate that their growth may be slowed upon hollow-fibre bioreactor expansion. Further analysis of key chondrogenic genes and in vitro cartilage forming capacity needs to be conducted in more donors to determine whether chondrogenic potential is influenced by up-scale manufacture."
}
</script>

  

  

  

  





  <title>Juvenile Chondrocytes: Novel Alternatives for Allogeneic Cell Therapy? | Oswestry Keele Orthopaedic Research group - OsKOR</title>
</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper   " data-wc-page-id="d8bf1f7d93bb3c573d69822aa2cef123" >

  
  
  
  
  
  
  
  
  
  <script src="/js/wowchemy-init.min.7e85d6cfe81caeb57cc49452f9b55e03.js"></script>

  




  <div class="page-header">
    











  


<header class="header--fixed">
  <nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
    <div class="container-xl">

      
      <div class="d-none d-lg-inline-flex">
        <a class="navbar-brand" href="/"><img src="/media/logo_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_0x70_resize_lanczos_3.png" alt="Oswestry Keele Orthopaedic Research group - OsKOR"
            
            ></a>
      </div>
      

      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar-content" aria-controls="navbar-content" aria-expanded="false" aria-label="Toggle navigation">
      <span><i class="fas fa-bars"></i></span>
      </button>
      

      
      <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
        <a class="navbar-brand" href="/"><img src="/media/logo_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_0x70_resize_lanczos_3.png" alt="Oswestry Keele Orthopaedic Research group - OsKOR"
          
          ></a>
      </div>
      

      
      
      <div class="navbar-collapse main-menu-item collapse justify-content-start" id="navbar-content">

        
        <ul class="navbar-nav d-md-inline-flex">
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
              
              
              
                
              
              
            
          

          <li class="nav-item">
            <a class="nav-link " href="/#about"><span>Home</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/people/"><span>Team</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/projects/"><span>Projects</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link  active" href="/publication/"><span>Publications</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/equipment/"><span>Equipment</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/post/"><span>Posts</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/events/"><span>Events</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/vacancies/"><span>Vacancies</span></a>
          </li>

          
          

        

          
        </ul>
      </div>

      <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">

        
        
          
        

        
        

        
        
        <li class="nav-item dropdown theme-dropdown">
          <a href="#" class="nav-link" data-toggle="dropdown" aria-haspopup="true" aria-label="Display preferences">
            <i class="fas fa-moon" aria-hidden="true"></i>
          </a>
          <div class="dropdown-menu">
            <a href="#" class="dropdown-item js-set-theme-light">
              <span>Light</span>
            </a>
            <a href="#" class="dropdown-item js-set-theme-dark">
              <span>Dark</span>
            </a>
            <a href="#" class="dropdown-item js-set-theme-auto">
              <span>Automatic</span>
            </a>
          </div>
        </li>
        

        
        

      </ul>

    </div>
  </nav>
</header>


  </div>

  <div class="page-body">
    








<div class="pub">

  












  

  
  
  
<div class="article-container pt-3">
  <h1>Juvenile Chondrocytes: Novel Alternatives for Allogeneic Cell Therapy?</h1>

  

  
    


<div class="article-metadata">

  
  
  
  
  <div>
    

  <span >
      <a href="/author/charlotte-hulme/">Charlotte Hulme</a></span>, <span >
      <a href="/author/john-garcia/">John Garcia</a></span>, <span >
      <a href="/author/robert-freeman/">Robert Freeman</a></span>, <span >
      <a href="/author/nigel-kiely/">Nigel Kiely</a></span>, <span >
      <a href="/author/derfel-williams/">Derfel Williams</a></span>, <span >
      <a href="/author/jonathan-wright/">Jonathan Wright</a></span>, <span >
      <a href="/author/karina-wright/">Karina Wright</a></span>
  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    April 2022
  </span>
  

  

  

  
  
  
  
  
  

  
  

</div>

    





  
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract">Purpose - Development of novel allogeneic chondrocyte therapies are needed to provide a more widespread, cost-effective cartilage treatment option. Here we investigate the potential of juvenile cartilage sources for allogeneic chondrocyte manufacture. <br><br> Methods and Materials - Juvenile polydactyly digit (PD; n=4; aged 1±1 years (med±IQR)) or iliac apophysis cartilage (IA; n=6; aged 1±0.5years (med±IQR)) was used to derive chondrocyte cultures. Juvenile chondrocyte growth was compared to adult chondrocytes used for Autologous Chondrocyte Implantation (n=11; aged 41±9 years (med±IQR)). Further, juvenile chondrocytes (PD, n=2; IA, n=3) were up-scale manufactured using the Quantum® hollow-fibre bioreactor and compared to traditional tissue culture plastic (TCP) methods. All data are mean±SD. <br><br> Results - Comparable chondrocyte yields were obtained from juvenile (IA: 4.3±3.8x103 cells/mg tissue; polydactyly: 4.2±4.2x103 cells/mg tissue) and adult (2.6±0.1x103 cells/mg tissue; p&gt;0.05; One-Way Anova) sources. In contrast, doubling time (DT) (passage 1-3) for PD chondrocytes grown on TCP (2.66±1.57days) was significantly lower than IA (5.17±2.66 days) and adult chondrocytes (9.98±10.29 days) (Paired t-tests; p&lt;0.05). Up-scale bioreactor expansion yielded 74.5±30 x106 PD and 76±14x106 IA chondrocytes in 11±1 days. DT was longer in the bioreactor cf. TCP (IA: bioreactor DT= 3.9±0.2 days, TCP DT= 2.0±0.3 days, t-test, p&lt;0.05; PD: bioreactor DT=3.8±1.0 days, TCP DT=1.3±0.0 days). Juvenile chondrocytes were immunopositive (&gt;95%) for CD90, CD73, CD44, CD166 and CD151 and immunonegative (&lt;2%) for CD19, CD34, and CD45 and no difference in immunoprofile was observed cf. TCP expansion (One-Way ANOVA). <br><br> Conclusion - Juvenile chondrocytes represent attractive allogeneic cells sources, yielding large numbers of chondrocytes. However, our preliminary analyses indicate that their growth may be slowed upon hollow-fibre bioreactor expansion. Further analysis of key chondrogenic genes and in vitro cartilage forming capacity needs to be conducted in more donors to determine whether chondrogenic potential is influenced by up-scale manufacture.</p>
    

    
    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            <a href="/publication/#1">
              Conference abstract
            </a>
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    

    <div class="space-below"></div>

    <div class="article-style">


</div>

    






<div class="article-tags">
  
  <a class="badge badge-light" href="/tag/chondrocyte/">Chondrocyte</a>
  
  <a class="badge badge-light" href="/tag/allogenic-cell-therapy/">Allogenic cell therapy</a>
  
</div>



<div class="share-box">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="https://twitter.com/intent/tweet?url=https://oskor.netlify.app/publication/juvenile-chondrocytes-novel-alternatives-for-allogeneic-cell-therapy/&amp;text=Juvenile%20Chondrocytes:%20Novel%20Alternatives%20for%20Allogeneic%20Cell%20Therapy?" target="_blank" rel="noopener" class="share-btn-twitter" aria-label="twitter">
          <i class="fab fa-twitter"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.facebook.com/sharer.php?u=https://oskor.netlify.app/publication/juvenile-chondrocytes-novel-alternatives-for-allogeneic-cell-therapy/&amp;t=Juvenile%20Chondrocytes:%20Novel%20Alternatives%20for%20Allogeneic%20Cell%20Therapy?" target="_blank" rel="noopener" class="share-btn-facebook" aria-label="facebook">
          <i class="fab fa-facebook"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=Juvenile%20Chondrocytes:%20Novel%20Alternatives%20for%20Allogeneic%20Cell%20Therapy?&amp;body=https://oskor.netlify.app/publication/juvenile-chondrocytes-novel-alternatives-for-allogeneic-cell-therapy/" target="_blank" rel="noopener" class="share-btn-email" aria-label="envelope">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=https://oskor.netlify.app/publication/juvenile-chondrocytes-novel-alternatives-for-allogeneic-cell-therapy/&amp;title=Juvenile%20Chondrocytes:%20Novel%20Alternatives%20for%20Allogeneic%20Cell%20Therapy?" target="_blank" rel="noopener" class="share-btn-linkedin" aria-label="linkedin-in">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="whatsapp://send?text=Juvenile%20Chondrocytes:%20Novel%20Alternatives%20for%20Allogeneic%20Cell%20Therapy?%20https://oskor.netlify.app/publication/juvenile-chondrocytes-novel-alternatives-for-allogeneic-cell-therapy/" target="_blank" rel="noopener" class="share-btn-whatsapp" aria-label="whatsapp">
          <i class="fab fa-whatsapp"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://service.weibo.com/share/share.php?url=https://oskor.netlify.app/publication/juvenile-chondrocytes-novel-alternatives-for-allogeneic-cell-therapy/&amp;title=Juvenile%20Chondrocytes:%20Novel%20Alternatives%20for%20Allogeneic%20Cell%20Therapy?" target="_blank" rel="noopener" class="share-btn-weibo" aria-label="weibo">
          <i class="fab fa-weibo"></i>
        </a>
      </li>
    
  </ul>
</div>











  
  
    




  
    




  
    




  
    




  
    




  
    




  
    




  










<div class="article-widget">
  
<div class="post-nav">
  
  
  
  <div class="post-nav-item">
    <div class="meta-nav">Next</div>
    <a href="/publication/human-umbilical-cord-derived-mesenchymal-stromal-cells-reduce-radiographic-osteoarthritis-in-an-ovine-model/" rel="next">Human Umbilical Cord-Derived Mesenchymal Stromal Cells Reduce Radiographic Osteoarthritis in an Ovine Model</a>
  </div>
  
  
  
  <div class="post-nav-item">
    <div class="meta-nav">Previous</div>
    <a href="/publication/macroscopic-assessment-of-articular-cartilage-quality-correlates-with-histological-assessment-of-subchondral-bone-health/" rel="prev">Macroscopic Assessment of Articular Cartilage Quality Correlates with Histological Assessment of Subchondral Bone Health</a>
  </div>
  
</div>

</div>





  
  
  <div class="article-widget content-widget-hr">
    <h3>Related</h3>
    <ul>
      
      <li><a href="/publication/cell-cultured-chondrocyte-implantation-and-scaffold-techniques-for-osteochondral-talar-lesions/">Cell cultured chondrocyte implantation and scaffold techniques for osteochondral talar lesions</a></li>
      
      <li><a href="/publication/chondrocyte-isolation-and-expansion/"> Chondrocyte Isolation and Expansion</a></li>
      
      <li><a href="/publication/cell-therapy-for-cartilage-repair/">Cell therapy for cartilage repair</a></li>
      
      <li><a href="/publication/chondrogenic-potency-analyses-of-donor-matched-chondrocytes-and-mesenchymal-stem-cells-derived-from-bone-marrow-infrapatellar-fat-pad-and-subcutaneous-fat/">Chondrogenic Potency Analyses of Donor-Matched Chondrocytes and Mesenchymal Stem Cells Derived from Bone Marrow, Infrapatellar Fat Pad, and Subcutaneous Fat</a></li>
      
      <li><a href="/publication/efficacy-and-safety-of-autologous-cell-therapies-for-knee-cartilage-defects-autologous-stem-cells-chondrocytes-or-the-two-randomized-controlled-trial-design/">Efficacy and safety of autologous cell therapies for knee cartilage defects (autologous stem cells, chondrocytes or the two): randomized controlled trial design</a></li>
      
    </ul>
  </div>
  





  </div>
</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">

  



  

  

  
  <p class="powered-by">
    © 2025
  </p>
  

  
  






  <p class="powered-by">
    
    
    
      
      
      
      
      
      
      Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target="_blank" rel="noopener">Wowchemy</a> — the free, <a href="https://github.com/wowchemy/wowchemy-hugo-themes" target="_blank" rel="noopener">open source</a> website builder that empowers creators.
    
  </p>
</footer>

    </div>
    
  </div>

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

      

    
    <script src="/js/vendor-bundle.min.0047d4febf356e7f0b988e541f50b065.js"></script>

    
    
    
      
      
        <script src="https://cdn.jsdelivr.net/gh/desandro/imagesloaded@v4.1.4/imagesloaded.pkgd.min.js" integrity="sha512-S5PZ9GxJZO16tT9r3WJp/Safn31eu8uWrzglMahDT4dsmgqWonRY9grk3j+3tfuPr9WJNsfooOR7Gi7HL5W2jw==" crossorigin="anonymous"></script>
        <script src="https://cdn.jsdelivr.net/gh/metafizzy/isotope@v3.0.6/dist/isotope.pkgd.min.js" integrity="sha512-Zq2BOxyhvnRFXu0+WE6ojpZLOU2jdnqbrM1hmVdGzyeCa1DgM3X5Q4A/Is9xA1IkbUeDd7755dNNI/PzSf2Pew==" crossorigin="anonymous"></script>
      

      
      

      
        <script src="https://cdn.jsdelivr.net/gh/mermaid-js/mermaid@v8.8.4/dist/mermaid.min.js" integrity="sha512-+TNmhaRJf3jyYHTpzEq/5I6b+aGyhzWb21mGdHAjxSGSYwxN9Grug3Y3B9qVxWfKKY8MscE/6mr9walWvFLFvQ==" crossorigin="anonymous" title="mermaid"></script>
      

      
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/highlight.min.js" integrity="sha512-Ypjm0o7jOxAd4hpdoppSEN0TQOC19UtPAqD+4s5AlXmUvbmmS/YMxYqAqarQYyxTnB6/rqip9qcxlNB/3U9Wdg==" crossorigin="anonymous"></script>
        
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/r.min.js" crossorigin="anonymous"></script>
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/python.min.js" crossorigin="anonymous"></script>
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/latex.min.js" crossorigin="anonymous"></script>
        
      

    

    
    
    

    
    

    
    
    

    
    

    
    
    
    

    
    

    

    
    
    
    <script id="page-data" type="application/json">{"use_headroom":true}</script>

    
    
      <script src="/js/wowchemy-headroom.6b73888494485d3b0874ca2ec83f614f.js" type="module"></script>
    
    
    
    
    
    
    
    
    <script src="/en/js/wowchemy.min.8d464630e57565cec18d704bd3ef621f.js"></script>

    






</body>
</html>
